Patents by Inventor Tapas HAZRA

Tapas HAZRA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions related to recombinant NEIL2
    Patent number: 11851464
    Abstract: Certain embodiments are directed to NEIL2 compositions and method of using NEIL2 composition to treat subjects in need of such treatment.
    Type: Grant
    Filed: April 11, 2022
    Date of Patent: December 26, 2023
    Assignee: Board of Regents, The University of Texas System
    Inventors: Tapas Hazra, Sanjiv Sur, Ashok Chopra
  • NEIL2 PROTEIN THERAPY FOR TREATMENT OF VIRAL INFECTION
    Publication number: 20230355725
    Abstract: Certain embodiments are directed to methods for treating a virus induced dysregulated inflammatory response in a subject in need of such treatment. The methods can include the administration a NEIL2 peptide or a composition comprising the NEIL2 peptide to the subject.
    Type: Application
    Filed: January 9, 2023
    Publication date: November 9, 2023
    Inventors: Tapas Hazra, Istvan Boldogh, Chien-Te K. Tseng
  • METHODS AND COMPOSITIONS RELATED TO RECOMBINANT NEIL2
    Publication number: 20220259274
    Abstract: Certain embodiments are directed to NEIL2 compositions and method of using NEIL2 composition to treat subjects in need of such treatment.
    Type: Application
    Filed: April 11, 2022
    Publication date: August 18, 2022
    Inventors: Tapas HAZRA, Sanjiv SUR, Ashok CHOPRA
  • METHODS AND COMPOSITIONS RELATED TO RECOMBINANT NEIL2
    Publication number: 20200102358
    Abstract: Certain embodiments are directed to NEIL2 compositions and method of using NEIL2 composition to treat subjects in need of such treatment.
    Type: Application
    Filed: September 27, 2019
    Publication date: April 2, 2020
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Tapas HAZRA, Sanjiv SUR, Ashok CHOPRA